IMMIX BIOPHARMA, INC. Shares Outstanding (Cover Page)
IMMIX BIOPHARMA, INC. (IMMX) had Shares Outstanding (Cover Page) of 71.54 million shares as of 2026-08-03, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-03: Entity Common Stock, Shares Outstanding 71.54M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 54.41M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 52.96M shares.
- 2025-11-05: Entity Common Stock, Shares Outstanding 33.58M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 71.54M shares 10-Q · filed 2026-08-07 |
| 2026-04-30 | 54.41M shares 10-Q · filed 2026-05-07 |
| 2026-03-20 | 52.96M shares 10-K/A · filed 2026-03-27 |
| 2025-11-05 | 33.58M shares 10-Q · filed 2025-11-07 |
| 2025-08-01 | 28.83M shares 10-Q · filed 2025-08-08 |
| 2025-05-06 | 27.88M shares 10-Q/A · filed 2025-05-19 |
| 2025-03-11 | 27.72M shares 10-K/A · filed 2025-05-19 |
| 2024-11-12 | 27.51M shares 10-Q · filed 2024-11-12 |
| 2024-08-12 | 27.45M shares 10-Q · filed 2024-08-12 |
| 2024-05-09 | 26.41M shares 10-Q · filed 2024-05-09 |
| 2024-03-29 | 26.40M shares 10-K · filed 2024-03-29 |
| 2023-11-09 | 19.87M shares 10-Q · filed 2023-11-13 |
| 2023-08-11 | 16.29M shares 10-Q · filed 2023-08-11 |
| 2023-05-11 | 15.03M shares 10-Q · filed 2023-05-12 |
| 2023-03-17 | 13.90M shares 10-K · filed 2023-03-27 |
| 2022-11-15 | 13.93M shares 10-Q · filed 2022-11-09 |
| 2022-08-11 | 13.91M shares 10-Q · filed 2022-08-12 |
| 2022-05-13 | 13.89M shares 10-Q · filed 2022-05-13 |
| 2022-03-23 | 13.86M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |